샘플 요청 목록

 카트 문의
시장보고서
상품코드
2029168

무균 충전 마감 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)

Aseptic Fill Finish Market Insights, Competitive Landscape, and Market Forecast - 2033
발행일: | 리서치사: 구분자 Fairfield Market Research | 페이지 정보: 영문 196 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



가격
Unprintable PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,995 금액 안내 화살표 ￦ 7,605,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.
US $ 8,495 금액 안내 화살표 ￦ 12,934,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,600 금액 안내 화살표 ￦ 16,139,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

제약회사와 생명공학 기업들이 의약품 제조에서 무균성, 정확성, 제품 무결성을 최우선 과제로 삼으면서 무균 충전 마감 시장은 지속적으로 성장하고 있습니다. 무균 처리는 제조 공정 전반에 걸쳐 섬세한 주사제가 오염되지 않도록 보장하기 위해 필수적입니다. 바이오의약품, 백신 및 첨단 치료법으로의 전환이 진행됨에 따라 신뢰할 수 있는 무균 충전 마감 솔루션에 대한 요구가 점점 더 중요해지고 있습니다. Persistence Market Research는 자동화, 로봇 공학, 폐쇄형 시스템 제조와 같은 기술적 진보를 통해 시장이 진화하고 있으며, 이는 업무 효율성과 컴플라이언스 표준을 변화시키고 있다고 지적합니다.

시장 인사이트

전 세계 무균 충전 마감 시장은 2026년에 63억 달러에 달할 것으로 추정되며, 2033년까지 5.30%의 CAGR로 90억 달러로 성장할 것으로 예상됩니다. 이러한 꾸준한 성장은 고도로 통제된 환경을 필요로 하는 주사제, 특히 바이오의약품과 바이오시밀러의 생산 증가에 힘입은 바 큽니다. 제조업체들은 오염 위험을 최소화하고 생산 성과를 향상시키기 위해 아이솔레이터, 제한적 접근 차단 시스템 등 첨단 무균 기술을 채택하고 있습니다. 또한, 프리필드 시린지, 바이알 등 RTU(Ready To Use) 용기의 사용 확대는 효율성을 높이고 처리 시간을 단축하여 시장 성장을 더욱 촉진하고 있습니다.

촉진요인

무균 충전 마감 시장을 이끄는 주요 요인은 바이오의약품 및 바이오시밀러의 급속한 확장입니다. 이러한 치료제는 제조 시 엄격한 무균 조건이 필요하기 때문에 무균 처리가 필수적입니다. 단클론항체, 백신, 유전자 치료제에 대한 수요가 증가함에 따라 첨단 충진 및 마감 솔루션의 도입이 크게 증가하고 있습니다.

엄격한 규제 요건도 시장 성장에 매우 중요한 역할을 하고 있습니다. 전 세계 규제 당국은 제품의 안전과 무균성을 보장하기 위해 엄격한 가이드라인을 시행하고 있으며, 이로 인해 제조업체는 최신 무균 기술에 투자해야 하는 상황에 처해 있습니다. 이러한 기준을 충족시키면서 정확성과 확장성을 향상시키기 위해 자동화 및 로봇 시스템이 생산 공정에 점점 더 많이 통합되고 있습니다.

또한, 만성질환에 대한 부담 증가와 주사제에 대한 수요 증가로 인해 무균 충전 및 포장 서비스의 필요성이 증가하고 있습니다. 주사제를 통한 약물전달은 여전히 많은 치료에서 선호되는 방법이며, 시장 수요를 더욱 강화하고 있습니다.

비즈니스 기회

이 시장에는 특히 위탁개발제조기관(CDMO)의 역할 확대를 통해 큰 비즈니스 기회가 존재합니다. 제약회사 및 생명공학 기업들은 비용 절감과 업무 효율화를 위해 무균 충전 및 포장 업무를 전문 서비스 제공업체에 아웃소싱하는 추세가 강화되고 있습니다. 이러한 추세는 유연하고 확장 가능한 제조 솔루션을 제공하는 CDMO에게 큰 성장 기회를 창출하고 있습니다.

또 다른 중요한 기회는 혁신적인 포장 솔루션에 있습니다. 프리필드 시린지, 카트리지 및 즉시 사용 가능한 바이알은 편리성, 오염 위험 감소 및 환자 복약 순응도 향상으로 인해 널리 보급되고 있습니다. 첨단 포장 기술에 집중하는 기업은 수요 증가로 인한 혜택을 누릴 가능성이 높습니다.

신흥국 시장도 새로운 성장의 길을 열고 있습니다. 아시아태평양 및 라틴아메리카 등 지역의 의료 인프라 확충, 의약품 생산량 증가 및 정부 지원책이 향후 시장 확대를 견인할 것으로 예상됩니다.

지역별 분석

북미는 강력한 제약 산업, 높은 제조 능력, 혁신적인 기술 보급률에 힘입어 무균 충전 마감 시장에서 지배적인 위치를 차지하고 있습니다. 또한, 이 지역은 바이오의약품에 대한 막대한 투자와 명확한 규제 환경의 혜택을 누리고 있습니다.

유럽은 활발한 연구개발 활동과 바이오시밀러에 대한 수요 증가에 힘입어 여전히 주요 시장으로 남아 있습니다. 독일, 프랑스, 영국 등의 국가들이 선두에 서서 기술 혁신과 엄격한 규제 기준을 준수하는 데 주력하고 있습니다.

아시아태평양은 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예상됩니다. 이 지역은 비용 우위, 의료 시스템 확장, 첨단 치료법에 대한 수요 증가로 인해 제약 제조의 주요 거점으로 부상하고 있습니다. 특히 중국과 인도에서는 무균 가공 및 위탁 제조 서비스에 많은 투자가 이루어지고 있습니다.

라틴아메리카와 중동 및 아프리카는 의료 인프라 개선과 의약품 제조에 대한 관심 증가에 힘입어 점차 확대되고 있습니다. 이들 지역에서는 투자가 계속 증가함에 따라 장기적인 성장 기회가 기대되는 지역입니다.

주요 기업

  • F. Hoffmann-La Roche Ltd.(Genentech)
  • Amgen Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson(Janssen Pharmaceuticals)
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Novartis AG
  • Sanofi S.A.
  • AstraZeneca plc
  • Genmab A/S
  • MacroGenics, Inc.
  • Xencor, Inc.
  • Merus N.V.

세분화

분자 유형별

  • 바이오로직스
  • 저분자 의약품
  • 바이오시밀러(제네릭 의약품에 포함)

포장 용기별

  • 바이알
  • 프리필드 시린지
  • 앰플
  • 카트리지
  • 가방

의약품 제품 유형별

  • 항체
  • 백신
  • 세포 치료
  • 유전자 치료
  • 재조합 단백질
  • 올리고뉴클레오티드
  • 기타

서비스 프로세스별

  • 제형
  • 무균 충전
  • 동결건조
  • 포장·마감

최종사용자별

  • 제약회사
  • 생명공학 기업
  • 위탁개발 및 제조기관(CDMO)
  • 연구기관

지역별

  • 북미
  • 북미
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

제3장 세계의 무균 충전 마감 시장 전망, 2020-2033년

제4장 북미의 무균 충전 마감 시장 전망, 2020-2033년

제5장 유럽의 무균 충전 마감 시장 전망, 2020-2033년

제6장 아시아태평양의 무균 충전 마감 시장 전망, 2020-2033년

제7장 라틴아메리카의 무균 충전 마감 시장 전망, 2020-2033년

제8장 중동 및 아프리카의 무균 충전 마감 시장 전망, 2020-2033년

제9장 경쟁 구도

제10장 부록

KSM

The aseptic fill finish market continues to gain momentum as pharmaceutical and biotechnology companies prioritize sterility, precision, and product integrity in drug manufacturing. Aseptic processing is essential for ensuring that sensitive injectable therapies remain free from contamination throughout production. With the growing shift toward biologics, vaccines, and advanced therapies, the need for reliable aseptic fill finish solutions is becoming increasingly critical. Persistence Market Research highlights that the market is evolving through technological advancements, including automation, robotics, and closed-system manufacturing, which are transforming operational efficiency and compliance standards.

Market Insights

The global aseptic fill finish market is estimated to reach US$ 6.3 billion in 2026 and is projected to grow to US$ 9 billion by 2033, expanding at a CAGR of 5.30%. This steady growth is largely driven by the rising production of injectable drugs, particularly biologics and biosimilars, which require highly controlled environments. Manufacturers are adopting advanced aseptic technologies such as isolators and restricted access barrier systems to minimize contamination risks and improve production outcomes. The increasing use of ready-to-use containers, including prefilled syringes and vials, is further supporting market growth by enhancing efficiency and reducing processing time.

Drivers

A major factor driving the aseptic fill finish market is the rapid expansion of biologics and biosimilars. These therapies require strict sterility conditions during manufacturing, making aseptic processing indispensable. The increasing demand for monoclonal antibodies, vaccines, and gene-based treatments is significantly boosting the adoption of advanced fill finish solutions.

Stringent regulatory requirements also play a vital role in market growth. Regulatory authorities worldwide are enforcing strict guidelines to ensure product safety and sterility, prompting manufacturers to invest in modern aseptic technologies. Automation and robotic systems are increasingly being integrated into production processes to meet these standards while improving accuracy and scalability.

In addition, the growing burden of chronic diseases and the rising demand for injectable medications are fueling the need for aseptic fill finish services. Injectable drug delivery remains a preferred method for many treatments, further strengthening market demand.

Business Opportunity

The market presents strong opportunities, particularly through the rising role of contract development and manufacturing organizations (CDMOs). Pharmaceutical and biotech companies are increasingly outsourcing aseptic fill finish operations to specialized service providers to reduce costs and streamline operations. This trend is creating significant growth avenues for CDMOs offering flexible and scalable manufacturing solutions.

Another key opportunity lies in innovative packaging solutions. Prefilled syringes, cartridges, and ready-to-use vials are gaining traction due to their convenience, reduced contamination risks, and improved patient compliance. Companies focusing on advanced packaging technologies are likely to benefit from increasing demand.

Emerging economies are also opening new growth pathways. Expanding healthcare infrastructure, increasing pharmaceutical production, and supportive government initiatives in regions such as Asia-Pacific and Latin America are expected to drive future market expansion.

Region Analysis

North America holds a dominant position in the aseptic fill finish market, supported by a strong pharmaceutical industry, advanced manufacturing capabilities, and high adoption of innovative technologies. The region also benefits from substantial investments in biologics and a well-defined regulatory environment.

Europe remains a key market, driven by strong research and development activities and increasing demand for biosimilars. Countries such as Germany, France, and the United Kingdom are at the forefront, focusing on technological innovation and compliance with stringent regulatory standards.

Asia-Pacific is anticipated to register the fastest growth over the forecast period. The region is emerging as a major hub for pharmaceutical manufacturing due to cost advantages, expanding healthcare systems, and rising demand for advanced therapies. China and India, in particular, are witnessing significant investments in aseptic processing and contract manufacturing services.

Latin America and the Middle East & Africa are gradually expanding, supported by improving healthcare infrastructure and increasing focus on pharmaceutical manufacturing. These regions are expected to offer long-term growth opportunities as investments continue to rise.

Key Players

  • F. Hoffmann-La Roche Ltd. (Genentech)
  • Amgen Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Novartis AG
  • Sanofi S.A.
  • AstraZeneca plc
  • Genmab A/S
  • MacroGenics, Inc.
  • Xencor, Inc.
  • Merus N.V.

Segmentation

By Molecule Type

  • Biologics
  • Small Molecules
  • Biosimilars (under generics)

By Packaging Container

  • Vials
  • Prefilled Syringes
  • Ampoules
  • Cartridges
  • Bags

By Drug Product Type

  • Antibodies
  • Vaccines
  • Cell Therapies
  • Gene Therapies
  • Recombinant Proteins
  • Oligonucleotides
  • Other Biologics

By Service Process

  • Formulation
  • Aseptic Filling
  • Lyophilization (Freeze Drying)
  • Packaging & Finishing

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Aseptic Fill Finish Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Aseptic Fill Finish Market Outlook, 2020-2033

  • 3.1. Global Aseptic Fill Finish Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Biologics
    • 3.1.2. Small Molecules
    • 3.1.3. Biosimilars (under generics)
  • 3.2. Global Aseptic Fill Finish Market Outlook, by Packaging Container, Value (US$ Bn), 2020-2033
    • 3.2.1. Vials
    • 3.2.2. Prefilled Syringes
    • 3.2.3. Ampoules
    • 3.2.4. Cartridges
    • 3.2.5. Bags
  • 3.3. Global Aseptic Fill Finish Market Outlook, by Drug Product Type, Value (US$ Bn), 2020-2033
    • 3.3.1. Antibodies
    • 3.3.2. Vaccines
    • 3.3.3. Cell Therapies
    • 3.3.4. Gene Therapies
    • 3.3.5. Recombinant Proteins
    • 3.3.6. Oligonucleotides
    • 3.3.7. Other Biologics
  • 3.4. Global Aseptic Fill Finish Market Outlook, by Service Process, Value (US$ Bn), 2020-2033
    • 3.4.1. Formulation
    • 3.4.2. Aseptic Filling
    • 3.4.3. Lyophilization (Freeze Drying)
    • 3.4.4. Packaging & Finishing
  • 3.5. Global Aseptic Fill Finish Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.5.1. Pharmaceutical Companies
    • 3.5.2. Biotechnology Companies
    • 3.5.3. Contract Development & Manufacturing Organizations (CDMOs)
    • 3.5.4. Research Institutes
  • 3.6. Global Aseptic Fill Finish Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.6.1. North America
    • 3.6.2. Europe
    • 3.6.3. Asia Pacific
    • 3.6.4. Latin America
    • 3.6.5. Middle East & Africa

4. North America Aseptic Fill Finish Market Outlook, 2020-2033

  • 4.1. North America Aseptic Fill Finish Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Biologics
    • 4.1.2. Small Molecules
    • 4.1.3. Biosimilars (under generics)
  • 4.2. North America Aseptic Fill Finish Market Outlook, by Packaging Container, Value (US$ Bn), 2020-2033
    • 4.2.1. Vials
    • 4.2.2. Prefilled Syringes
    • 4.2.3. Ampoules
    • 4.2.4. Cartridges
    • 4.2.5. Bags
  • 4.3. North America Aseptic Fill Finish Market Outlook, by Drug Product Type, Value (US$ Bn), 2020-2033
    • 4.3.1. Antibodies
    • 4.3.2. Vaccines
    • 4.3.3. Cell Therapies
    • 4.3.4. Gene Therapies
    • 4.3.5. Recombinant Proteins
    • 4.3.6. Oligonucleotides
    • 4.3.7. Other Biologics
  • 4.4. North America Aseptic Fill Finish Market Outlook, by Service Process, Value (US$ Bn), 2020-2033
    • 4.4.1. Formulation
    • 4.4.2. Aseptic Filling
    • 4.4.3. Lyophilization (Freeze Drying)
    • 4.4.4. Packaging & Finishing
  • 4.5. North America Aseptic Fill Finish Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.5.1. Pharmaceutical Companies
    • 4.5.2. Biotechnology Companies
    • 4.5.3. Contract Development & Manufacturing Organizations (CDMOs)
    • 4.5.4. Research Institutes
  • 4.6. North America Aseptic Fill Finish Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.6.1. U.S. Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 4.6.2. U.S. Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 4.6.3. U.S. Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 4.6.4. U.S. Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 4.6.5. U.S. Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 4.6.6. Canada Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 4.6.7. Canada Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 4.6.8. Canada Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 4.6.9. Canada Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 4.6.10. Canada Aseptic Fill Finish Market Outlook, by End User, 2020-2033
  • 4.7. BPS Analysis/Market Attractiveness Analysis

5. Europe Aseptic Fill Finish Market Outlook, 2020-2033

  • 5.1. Europe Aseptic Fill Finish Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Biologics
    • 5.1.2. Small Molecules
    • 5.1.3. Biosimilars (under generics)
  • 5.2. Europe Aseptic Fill Finish Market Outlook, by Packaging Container, Value (US$ Bn), 2020-2033
    • 5.2.1. Vials
    • 5.2.2. Prefilled Syringes
    • 5.2.3. Ampoules
    • 5.2.4. Cartridges
    • 5.2.5. Bags
  • 5.3. Europe Aseptic Fill Finish Market Outlook, by Drug Product Type, Value (US$ Bn), 2020-2033
    • 5.3.1. Antibodies
    • 5.3.2. Vaccines
    • 5.3.3. Cell Therapies
    • 5.3.4. Gene Therapies
    • 5.3.5. Recombinant Proteins
    • 5.3.6. Oligonucleotides
    • 5.3.7. Other Biologics
  • 5.4. Europe Aseptic Fill Finish Market Outlook, by Service Process, Value (US$ Bn), 2020-2033
    • 5.4.1. Formulation
    • 5.4.2. Aseptic Filling
    • 5.4.3. Lyophilization (Freeze Drying)
    • 5.4.4. Packaging & Finishing
  • 5.5. Europe Aseptic Fill Finish Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.5.1. Pharmaceutical Companies
    • 5.5.2. Biotechnology Companies
    • 5.5.3. Contract Development & Manufacturing Organizations (CDMOs)
    • 5.5.4. Research Institutes
  • 5.6. Europe Aseptic Fill Finish Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.6.1. Germany Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.2. Germany Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.3. Germany Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.4. Germany Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.5. Germany Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 5.6.6. Italy Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.7. Italy Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.8. Italy Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.9. Italy Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.10. Italy Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 5.6.11. France Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.12. France Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.13. France Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.14. France Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.15. France Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 5.6.16. U.K. Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.17. U.K. Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.18. U.K. Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.19. U.K. Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.20. U.K. Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 5.6.21. Spain Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.22. Spain Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.23. Spain Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.24. Spain Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.25. Spain Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 5.6.26. Russia Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.27. Russia Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.28. Russia Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.29. Russia Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.30. Russia Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 5.6.31. Rest of Europe Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 5.6.32. Rest of Europe Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 5.6.33. Rest of Europe Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 5.6.34. Rest of Europe Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 5.6.35. Rest of Europe Aseptic Fill Finish Market Outlook, by End User, 2020-2033
  • 5.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aseptic Fill Finish Market Outlook, 2020-2033

  • 6.1. Asia Pacific Aseptic Fill Finish Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Biologics
    • 6.1.2. Small Molecules
    • 6.1.3. Biosimilars (under generics)
  • 6.2. Asia Pacific Aseptic Fill Finish Market Outlook, by Packaging Container, Value (US$ Bn), 2020-2033
    • 6.2.1. Vials
    • 6.2.2. Prefilled Syringes
    • 6.2.3. Ampoules
    • 6.2.4. Cartridges
    • 6.2.5. Bags
  • 6.3. Asia Pacific Aseptic Fill Finish Market Outlook, by Drug Product Type, Value (US$ Bn), 2020-2033
    • 6.3.1. Antibodies
    • 6.3.2. Vaccines
    • 6.3.3. Cell Therapies
    • 6.3.4. Gene Therapies
    • 6.3.5. Recombinant Proteins
    • 6.3.6. Oligonucleotides
    • 6.3.7. Other Biologics
  • 6.4. Asia Pacific Aseptic Fill Finish Market Outlook, by Service Process, Value (US$ Bn), 2020-2033
    • 6.4.1. Formulation
    • 6.4.2. Aseptic Filling
    • 6.4.3. Lyophilization (Freeze Drying)
    • 6.4.4. Packaging & Finishing
  • 6.5. Asia Pacific Aseptic Fill Finish Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.5.1. Pharmaceutical Companies
    • 6.5.2. Biotechnology Companies
    • 6.5.3. Contract Development & Manufacturing Organizations (CDMOs)
    • 6.5.4. Research Institutes
  • 6.6. Asia Pacific Aseptic Fill Finish Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.6.1. China Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 6.6.2. China Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 6.6.3. China Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 6.6.4. China Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 6.6.5. China Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 6.6.6. Japan Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 6.6.7. Japan Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 6.6.8. Japan Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 6.6.9. Japan Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 6.6.10. Japan Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 6.6.11. South Korea Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 6.6.12. South Korea Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 6.6.13. South Korea Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 6.6.14. South Korea Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 6.6.15. South Korea Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 6.6.16. India Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 6.6.17. India Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 6.6.18. India Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 6.6.19. India Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 6.6.20. India Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 6.6.21. Southeast Asia Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 6.6.22. Southeast Asia Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 6.6.23. Southeast Asia Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 6.6.24. Southeast Asia Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 6.6.25. Southeast Asia Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 6.6.26. Rest of SAO Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 6.6.27. Rest of SAO Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 6.6.28. Rest of SAO Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 6.6.29. Rest of SAO Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 6.6.30. Rest of SAO Aseptic Fill Finish Market Outlook, by End User, 2020-2033
  • 6.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aseptic Fill Finish Market Outlook, 2020-2033

  • 7.1. Latin America Aseptic Fill Finish Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Biologics
    • 7.1.2. Small Molecules
    • 7.1.3. Biosimilars (under generics)
  • 7.2. Latin America Aseptic Fill Finish Market Outlook, by Packaging Container, Value (US$ Bn), 2020-2033
    • 7.2.1. Vials
    • 7.2.2. Prefilled Syringes
    • 7.2.3. Ampoules
    • 7.2.4. Cartridges
    • 7.2.5. Bags
  • 7.3. Latin America Aseptic Fill Finish Market Outlook, by Drug Product Type, Value (US$ Bn), 2020-2033
    • 7.3.1. Antibodies
    • 7.3.2. Vaccines
    • 7.3.3. Cell Therapies
    • 7.3.4. Gene Therapies
    • 7.3.5. Recombinant Proteins
    • 7.3.6. Oligonucleotides
    • 7.3.7. Other Biologics
  • 7.4. Latin America Aseptic Fill Finish Market Outlook, by Service Process, Value (US$ Bn), 2020-2033
    • 7.4.1. Formulation
    • 7.4.2. Aseptic Filling
    • 7.4.3. Lyophilization (Freeze Drying)
    • 7.4.4. Packaging & Finishing
  • 7.5. Latin America Aseptic Fill Finish Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.5.1. Pharmaceutical Companies
    • 7.5.2. Biotechnology Companies
    • 7.5.3. Contract Development & Manufacturing Organizations (CDMOs)
    • 7.5.4. Research Institutes
  • 7.6. Latin America Aseptic Fill Finish Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.6.1. Brazil Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 7.6.2. Brazil Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 7.6.3. Brazil Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 7.6.4. Brazil Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 7.6.5. Brazil Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 7.6.6. Mexico Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 7.6.7. Mexico Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 7.6.8. Mexico Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 7.6.9. Mexico Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 7.6.10. Mexico Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 7.6.11. Argentina Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 7.6.12. Argentina Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 7.6.13. Argentina Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 7.6.14. Argentina Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 7.6.15. Argentina Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 7.6.16. Rest of LATAM Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 7.6.17. Rest of LATAM Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 7.6.18. Rest of LATAM Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 7.6.19. Rest of LATAM Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 7.6.20. Rest of LATAM Aseptic Fill Finish Market Outlook, by End User, 2020-2033
  • 7.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aseptic Fill Finish Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Aseptic Fill Finish Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Biologics
    • 8.1.2. Small Molecules
    • 8.1.3. Biosimilars (under generics)
  • 8.2. Middle East & Africa Aseptic Fill Finish Market Outlook, by Packaging Container, Value (US$ Bn), 2020-2033
    • 8.2.1. Vials
    • 8.2.2. Prefilled Syringes
    • 8.2.3. Ampoules
    • 8.2.4. Cartridges
    • 8.2.5. Bags
  • 8.3. Middle East & Africa Aseptic Fill Finish Market Outlook, by Drug Product Type, Value (US$ Bn), 2020-2033
    • 8.3.1. Antibodies
    • 8.3.2. Vaccines
    • 8.3.3. Cell Therapies
    • 8.3.4. Gene Therapies
    • 8.3.5. Recombinant Proteins
    • 8.3.6. Oligonucleotides
    • 8.3.7. Other Biologics
  • 8.4. Middle East & Africa Aseptic Fill Finish Market Outlook, by Service Process, Value (US$ Bn), 2020-2033
    • 8.4.1. Formulation
    • 8.4.2. Aseptic Filling
    • 8.4.3. Lyophilization (Freeze Drying)
    • 8.4.4. Packaging & Finishing
  • 8.5. Middle East & Africa Aseptic Fill Finish Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.5.1. Pharmaceutical Companies
    • 8.5.2. Biotechnology Companies
    • 8.5.3. Contract Development & Manufacturing Organizations (CDMOs)
    • 8.5.4. Research Institutes
  • 8.6. Middle East & Africa Aseptic Fill Finish Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.6.1. GCC Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 8.6.2. GCC Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 8.6.3. GCC Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 8.6.4. GCC Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 8.6.5. GCC Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 8.6.6. South Africa Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 8.6.7. South Africa Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 8.6.8. South Africa Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 8.6.9. South Africa Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 8.6.10. South Africa Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 8.6.11. Egypt Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 8.6.12. Egypt Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 8.6.13. Egypt Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 8.6.14. Egypt Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 8.6.15. Egypt Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 8.6.16. Nigeria Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 8.6.17. Nigeria Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 8.6.18. Nigeria Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 8.6.19. Nigeria Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 8.6.20. Nigeria Aseptic Fill Finish Market Outlook, by End User, 2020-2033
    • 8.6.21. Rest of Middle East Aseptic Fill Finish Market Outlook, by Molecule Type, 2020-2033
    • 8.6.22. Rest of Middle East Aseptic Fill Finish Market Outlook, by Packaging Container, 2020-2033
    • 8.6.23. Rest of Middle East Aseptic Fill Finish Market Outlook, by Drug Product Type, 2020-2033
    • 8.6.24. Rest of Middle East Aseptic Fill Finish Market Outlook, by Service Process, 2020-2033
    • 8.6.25. Rest of Middle East Aseptic Fill Finish Market Outlook, by End User, 2020-2033
  • 8.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. F. Hoffmann-La Roche Ltd. (Genentech)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Amgen Inc.
    • 9.4.3. Regeneron Pharmaceuticals, Inc.
    • 9.4.4. Bristol-Myers Squibb Company
    • 9.4.5. Johnson & Johnson (Janssen Pharmaceuticals)
    • 9.4.6. Pfizer Inc.
    • 9.4.7. Merck & Co., Inc.
    • 9.4.8. AbbVie Inc.
    • 9.4.9. Novartis AG
    • 9.4.10. Sanofi S.A.

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기